HUP0401597A2 - Metilén-4-azaszteroidok, eljárás az előállításukra és ezeket tartalmazó gyógyszerkészítmények - Google Patents
Metilén-4-azaszteroidok, eljárás az előállításukra és ezeket tartalmazó gyógyszerkészítményekInfo
- Publication number
- HUP0401597A2 HUP0401597A2 HU0401597A HUP0401597A HUP0401597A2 HU P0401597 A2 HUP0401597 A2 HU P0401597A2 HU 0401597 A HU0401597 A HU 0401597A HU P0401597 A HUP0401597 A HU P0401597A HU P0401597 A2 HUP0401597 A2 HU P0401597A2
- Authority
- HU
- Hungary
- Prior art keywords
- azasteroids
- methylene
- preparation
- pharmaceutical compositions
- compositions containing
- Prior art date
Links
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- MUMGGOZAMZWBJJ-DYKIIFRCSA-N Testostosterone Chemical compound O=C1CC[C@]2(C)[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CCC2=C1 MUMGGOZAMZWBJJ-DYKIIFRCSA-N 0.000 abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 2
- NVKAWKQGWWIWPM-ABEVXSGRSA-N 17-β-hydroxy-5-α-Androstan-3-one Chemical compound C1C(=O)CC[C@]2(C)[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CC[C@H]21 NVKAWKQGWWIWPM-ABEVXSGRSA-N 0.000 abstract 1
- 239000002677 5-alpha reductase inhibitor Substances 0.000 abstract 1
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 abstract 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 abstract 1
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 abstract 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract 1
- 229960003473 androstanolone Drugs 0.000 abstract 1
- 239000008280 blood Substances 0.000 abstract 1
- 210000004369 blood Anatomy 0.000 abstract 1
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 abstract 1
- 229910052794 bromium Inorganic materials 0.000 abstract 1
- 229910052801 chlorine Inorganic materials 0.000 abstract 1
- 239000000460 chlorine Substances 0.000 abstract 1
- 125000004093 cyano group Chemical group *C#N 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 229910052731 fluorine Inorganic materials 0.000 abstract 1
- 239000011737 fluorine Substances 0.000 abstract 1
- 239000001257 hydrogen Substances 0.000 abstract 1
- 229910052739 hydrogen Inorganic materials 0.000 abstract 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 abstract 1
- 239000000825 pharmaceutical preparation Substances 0.000 abstract 1
- 229960003604 testosterone Drugs 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J73/00—Steroids in which the cyclopenta[a]hydrophenanthrene skeleton has been modified by substitution of one or two carbon atoms by hetero atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J73/00—Steroids in which the cyclopenta[a]hydrophenanthrene skeleton has been modified by substitution of one or two carbon atoms by hetero atoms
- C07J73/001—Steroids in which the cyclopenta[a]hydrophenanthrene skeleton has been modified by substitution of one or two carbon atoms by hetero atoms by one hetero atom
- C07J73/005—Steroids in which the cyclopenta[a]hydrophenanthrene skeleton has been modified by substitution of one or two carbon atoms by hetero atoms by one hetero atom by nitrogen as hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/06—Antiabortive agents; Labour repressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/10—Anti-acne agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/14—Drugs for dermatological disorders for baldness or alopecia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/28—Antiandrogens
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Endocrinology (AREA)
- Diabetes (AREA)
- Dermatology (AREA)
- Reproductive Health (AREA)
- Gynecology & Obstetrics (AREA)
- Pregnancy & Childbirth (AREA)
- Urology & Nephrology (AREA)
- Steroid Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
A találmány új, (I) általános képletű - ahol R20 és R20a jelentéseegymástól függetlenül fluor-, klór-, brómatom vagy cianocsoport; R4 ésR10 jelentése hidrogénatom vagy metilcsoport; és R1 és R2 jelentésehidrogénatom vagy együtt képzett kötés - 17-metilén-4-azaszteroidokkalfoglalkozik. A találmány szerinti vegyületek az 5a-reduktázinhibitorai, alkalmasak ezáltal a vér és a szövetek tesztoszteron ésvégül dihidrotesztoszteron megemelkedett szintjével összefüggőbetegségek gyógykezelésére. A találmány kiterjed a vegyületekelőállítására és ezeket tartalmazó gyógyszerkészítményekre is. Ó
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE10141984A DE10141984A1 (de) | 2001-08-28 | 2001-08-28 | Neue 17-Methylen-4-azasteroide |
| PCT/EP2002/009587 WO2003020744A1 (de) | 2001-08-28 | 2002-08-28 | Methylen-4-azasteroide |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| HUP0401597A2 true HUP0401597A2 (hu) | 2004-12-28 |
| HUP0401597A3 HUP0401597A3 (en) | 2011-02-28 |
Family
ID=7696782
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HU0401597A HUP0401597A3 (en) | 2001-08-28 | 2002-08-28 | Methylene-4-azasteroids, process for their preparation and pharmaceutical compositions containing them |
Country Status (22)
| Country | Link |
|---|---|
| US (1) | US7186728B2 (hu) |
| EP (1) | EP1409513B1 (hu) |
| JP (1) | JP3927174B2 (hu) |
| KR (1) | KR100550514B1 (hu) |
| CN (1) | CN1322002C (hu) |
| AT (1) | ATE323100T1 (hu) |
| AU (1) | AU2002342625B8 (hu) |
| BR (1) | BR0212104A (hu) |
| CA (1) | CA2458932C (hu) |
| CY (1) | CY1105083T1 (hu) |
| DE (2) | DE10141984A1 (hu) |
| DK (1) | DK1409513T3 (hu) |
| ES (1) | ES2262856T3 (hu) |
| HK (1) | HK1071376A1 (hu) |
| HU (1) | HUP0401597A3 (hu) |
| IL (2) | IL160540A0 (hu) |
| NO (1) | NO326564B1 (hu) |
| PL (1) | PL367460A1 (hu) |
| PT (1) | PT1409513E (hu) |
| RU (1) | RU2293740C2 (hu) |
| WO (1) | WO2003020744A1 (hu) |
| ZA (1) | ZA200402368B (hu) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN110643557B (zh) * | 2019-04-23 | 2021-12-31 | 天津科技大学 | 一种基因工程菌的构建及其在高效催化5α-雄烯二酮生产中的应用 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5264427A (en) * | 1992-01-29 | 1993-11-23 | Research Corporation Technologies, Inc. | 20-substituted pregnene derivatives and their use as androgen synthesis inhibitors |
| US5763361A (en) * | 1995-10-23 | 1998-06-09 | Merck & Co., Inc. | 17-alkyl-7-substituted-4-aza steroid derivatives as 5-α-reductase inhibitors |
| ES2160842T3 (es) * | 1995-10-23 | 2001-11-16 | Merck & Co Inc | Derivados de esteroides 17-alquil-4-aza-7-sustituidos. |
| US5994334A (en) | 1997-02-05 | 1999-11-30 | University Of Maryland | Androgen synthesis inhibitors |
| AU2001268661A1 (en) * | 2000-06-27 | 2002-01-08 | Aventis Pharma S.A. | 20-fluoro-17(20)-vinyl steroids as inhibitors of c17-20-lyase and 5-alpha reductase |
| DE10043846A1 (de) * | 2000-09-04 | 2002-04-04 | Jenapharm Gmbh | 17-Methylensteroide, Verfahren zu deren Herstellung und diese Verbindung enthaltende pharmazeutische Zusammensetzungen |
-
2001
- 2001-08-28 DE DE10141984A patent/DE10141984A1/de not_active Withdrawn
-
2002
- 2002-08-28 EP EP02779279A patent/EP1409513B1/de not_active Expired - Lifetime
- 2002-08-28 CA CA002458932A patent/CA2458932C/en not_active Expired - Fee Related
- 2002-08-28 AU AU2002342625A patent/AU2002342625B8/en not_active Ceased
- 2002-08-28 KR KR1020047002922A patent/KR100550514B1/ko not_active IP Right Cessation
- 2002-08-28 DK DK02779279T patent/DK1409513T3/da active
- 2002-08-28 AT AT02779279T patent/ATE323100T1/de not_active IP Right Cessation
- 2002-08-28 PT PT02779279T patent/PT1409513E/pt unknown
- 2002-08-28 ES ES02779279T patent/ES2262856T3/es not_active Expired - Lifetime
- 2002-08-28 CN CNB028170814A patent/CN1322002C/zh not_active Expired - Fee Related
- 2002-08-28 WO PCT/EP2002/009587 patent/WO2003020744A1/de active IP Right Grant
- 2002-08-28 US US10/487,862 patent/US7186728B2/en not_active Expired - Fee Related
- 2002-08-28 IL IL16054002A patent/IL160540A0/xx unknown
- 2002-08-28 PL PL02367460A patent/PL367460A1/xx unknown
- 2002-08-28 JP JP2003525014A patent/JP3927174B2/ja not_active Expired - Fee Related
- 2002-08-28 DE DE50206397T patent/DE50206397D1/de not_active Expired - Lifetime
- 2002-08-28 HU HU0401597A patent/HUP0401597A3/hu unknown
- 2002-08-28 RU RU2004109166/04A patent/RU2293740C2/ru not_active IP Right Cessation
- 2002-08-28 BR BR0212104-2A patent/BR0212104A/pt not_active IP Right Cessation
-
2004
- 2004-02-24 IL IL160540A patent/IL160540A/en not_active IP Right Cessation
- 2004-03-25 ZA ZA200402368A patent/ZA200402368B/en unknown
- 2004-03-26 NO NO20041279A patent/NO326564B1/no not_active IP Right Cessation
-
2005
- 2005-05-24 HK HK05104308A patent/HK1071376A1/xx not_active IP Right Cessation
-
2006
- 2006-07-10 CY CY20061100960T patent/CY1105083T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| HK1071376A1 (en) | 2005-07-15 |
| RU2004109166A (ru) | 2005-10-10 |
| WO2003020744A1 (de) | 2003-03-13 |
| ES2262856T3 (es) | 2006-12-01 |
| US20040248921A1 (en) | 2004-12-09 |
| CN1549822A (zh) | 2004-11-24 |
| DE50206397D1 (de) | 2006-05-24 |
| DK1409513T3 (da) | 2006-08-14 |
| PT1409513E (pt) | 2006-08-31 |
| PL367460A1 (en) | 2005-02-21 |
| IL160540A (en) | 2009-11-18 |
| JP2005504786A (ja) | 2005-02-17 |
| ATE323100T1 (de) | 2006-04-15 |
| CA2458932C (en) | 2008-07-22 |
| BR0212104A (pt) | 2004-08-24 |
| RU2293740C2 (ru) | 2007-02-20 |
| AU2002342625B2 (en) | 2008-12-04 |
| EP1409513B1 (de) | 2006-04-12 |
| JP3927174B2 (ja) | 2007-06-06 |
| HUP0401597A3 (en) | 2011-02-28 |
| AU2002342625B8 (en) | 2009-01-08 |
| CN1322002C (zh) | 2007-06-20 |
| IL160540A0 (en) | 2004-07-25 |
| CY1105083T1 (el) | 2009-11-04 |
| ZA200402368B (en) | 2005-05-20 |
| CA2458932A1 (en) | 2003-03-13 |
| US7186728B2 (en) | 2007-03-06 |
| NO20041279L (no) | 2004-03-26 |
| NO326564B1 (no) | 2009-01-12 |
| EP1409513A1 (de) | 2004-04-21 |
| DE10141984A1 (de) | 2003-03-20 |
| KR100550514B1 (ko) | 2006-02-13 |
| KR20040032978A (ko) | 2004-04-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HUP0303354A2 (hu) | Gyulladásgátló hatású 6-alfa, 9-alfa-difluor-17-alfa-(2-furanilkarbonil)oxi-11-béta-hidroxi-16-alfa-metil-3-oxo-androst-1,4-dién-17-tiokarbonsav-S-fluormetil-észter, eljárás az előállítására és ezt tartalmazó gyógyszerkészítmény | |
| SE0104340D0 (sv) | New compounds | |
| SE9902987D0 (sv) | Novel compounds | |
| IS6520A (is) | Ný efnasambönd | |
| CY1115117T1 (el) | Παραγωγα υποκατεστημενων οξαζολιδινονων και η χρηση τους ως αναστολεις παραγοντα χα | |
| NO20042596L (no) | Inbibitorer av 11-beta-hydroksy steroid dehydrogenase type 1 | |
| NO20093464L (no) | Nye medikamentblandinger basert pa anti-cholinergisk effektive forbindelser og beta-mimetika | |
| SE0001899D0 (sv) | New compounds | |
| HUP0105077A2 (hu) | Szerin-proteáz inhibitorok és ezeket tartalmazó gyógyszerkészítmények | |
| DE60226729D1 (de) | Hydroxyalkylaminderivate als beta-secretase-inhibitoren und deren verwendung zur behandlung der alzheimerschen krankheit oder ähnlicher krankheiten | |
| IS6658A (is) | Ný efnasambönd | |
| WO2004043954A3 (en) | Trans-9,10-dehydroepothilone c and d, analogs thereof and methos of making the same | |
| MX2007011695A (es) | Derivados de oxindol sustituido, medicamentos que contienen dichos derivados y uso de los mismos. | |
| EP1689713A4 (en) | BENZYLETHER AND BETA-SECRETASE BENZYLAMINO INHIBITORS FOR TREATING ALZHEIMER'S DISEASE | |
| DE60045508D1 (de) | Dalda-analoge und ihre verwendung | |
| WO2003106450A8 (de) | Phenylaminopyrimidine und ihre verwendung als rho-kinase inhibitoren | |
| DE60221283D1 (de) | Verwendung von oxindolderivaten zur behandlung von mit demenz in zusammenhang stehenden krankheiten, alzheimer-krankheit und mit glycogensynthasekinase-3 assoziierten leiden | |
| CL2003002565A1 (es) | Compuestos derivados de 3h-quinazolin-4-ona, su proceso de preparacion, composicion farmaceutica que los contiene, y uso en el tratamiento y prevencion de enfermedades mediadas por inhibidores de mao-b, tales como la enfermedad de alzheimer y demenci | |
| RS19504A (en) | Novel compounds and compositions as cathepsin inhibitors | |
| SE0300456D0 (sv) | Novel compounds | |
| RS94603A (en) | Novel compounds and compositions as cathepsin inhibitors | |
| ATE369348T1 (de) | Zyklisierte benzamid-neurokinin-antagonisten zur verwendung in therapie | |
| GB0120461D0 (en) | Novel compounds | |
| SE9902551D0 (sv) | Novel compounds | |
| HUP0401597A2 (hu) | Metilén-4-azaszteroidok, eljárás az előállításukra és ezeket tartalmazó gyógyszerkészítmények |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FD9A | Lapse of provisional protection due to non-payment of fees |